Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TIMOTHY EDWARD RYAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1760914717
CMS profile
11304650
Location
RALEIGH, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$58,416.20

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TIMOTHY EDWARD RYAN

NPI 1760914717 · CMS profile ID 11304650

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

RALEIGH, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1760914717?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TIMOTHY EDWARD RYAN, NPI 1760914717, CMS profile ID 11304650. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1760914717?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). TIMOTHY EDWARD RYAN, NPI 1760914717, CMS profile ID 11304650. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1760914717?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
TIMOTHY EDWARD RYAN, NPI 1760914717, CMS profile ID 11304650, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1760914717?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $58,416.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $23.0007/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223881759 CMS
ABBVIE INC. $15.6407/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203983046 CMS
Janssen Biotech, Inc. $17.0707/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175106139 CMS
Janssen Biotech, Inc. $3,885.0007/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1175106447 CMS
Janssen Biotech, Inc. $13.9607/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175106956 CMS
Janssen Biotech, Inc. $64.0007/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1175108243 CMS
Neurelis, Inc. $17.3307/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219200231 CMS
ARGENX US, INC. $15.1707/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240445185 CMS
Janssen Biotech, Inc. $22.4006/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175104996 CMS
Janssen Biotech, Inc. $39.9806/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175106639 CMS
Janssen Biotech, Inc. $41.0406/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175109435 CMS
Janssen Biotech, Inc. $272.4106/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1175105921 CMS
Janssen Biotech, Inc. $226.8606/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1175106795 CMS
Janssen Biotech, Inc. $216.8606/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1175108248 CMS
Janssen Biotech, Inc. $14.4006/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175108019 CMS
Eisai Inc. $14.6706/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244516629 CMS
Alnylam Pharmaceuticals Inc. $21.9406/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742521 CMS
UCB, Inc. $26.1406/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679376 CMS
UCB, Inc. $24.5506/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679372 CMS
UCB, Inc. $8.7105/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679368 CMS
ARGENX US, INC. $21.4405/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240433401 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,473.5005/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1223794410 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.4105/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223802258 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7.5305/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223803224 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7.8805/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223803552 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.5205/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223861832 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.8505/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224096688 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.1905/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224096702 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.0005/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224096782 CMS
Takeda Pharmaceuticals U.S.A., Inc. $64.0005/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224097186 CMS
UCB, Inc. $17.2705/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679363 CMS
Alexion Pharmaceuticals, Inc. $25.2905/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202931122 CMS
Takeda Pharmaceuticals U.S.A., Inc. $123.8404/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223941484 CMS
Takeda Pharmaceuticals U.S.A., Inc. $228.7004/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224097750 CMS
Takeda Pharmaceuticals U.S.A., Inc. $387.7204/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224098080 CMS
Takeda Pharmaceuticals U.S.A., Inc. $547.1904/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224098338 CMS
Otsuka America Pharmaceutical, Inc. $17.2804/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227476877 CMS
UCB, Inc. $19.9604/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679360 CMS
ACADIA Pharmaceuticals Inc $23.0804/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247796767 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,306.5004/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1223794271 CMS
Takeda Pharmaceuticals U.S.A., Inc. $284.9004/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224097872 CMS
CSL Behring $21.6504/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232388653 CMS
UCB, Inc. $23.8504/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224679358 CMS
Neurelis, Inc. $16.5804/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219200229 CMS
LivaNova USA, Inc. $103.9703/31/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1245690537 CMS
LivaNova USA, Inc. $234.8203/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245690533 CMS
LivaNova USA, Inc. $362.9703/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1245690529 CMS
Eisai Inc. $23.1103/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244516627 CMS
Takeda Pharmaceuticals U.S.A., Inc. $122.8303/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223941442 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.0003/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224097100 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $131.15 2
PY2022 $261.94 14
PY2023 $1,075.95 47
PY2024 $25,315.03 92
PY2025 $58,416.20 134

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $37,798.00 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $18,500.00 11/22/2025 Non-covered Recipient Entity
Velocity Clinical Research
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures No dispute reported 06/30/2026 1233745780
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $169.00 11/12/2025 Non-covered Recipient Entity
WCG Clinical, Inc. WCG IRB, LLC
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures No dispute reported 06/30/2026 1233746330
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,915.00 11/03/2025 Non-covered Recipient Entity
WCG Clinical, Inc. WCG IRB, LLC
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures No dispute reported 06/30/2026 1233746328
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,500.00 07/30/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH INC
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223283256
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $9,520.00 07/30/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH INC
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223283258
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,300.00 07/30/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH INC
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223283260
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $135.00 07/01/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223281924
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,312.00 06/01/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223280530
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,312.00 05/01/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH - RALEIGH NEUROLOGY ASSOCIATES
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223278732
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $135.00 05/01/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH - RALEIGH NEUROLOGY ASSOCIATES
A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) No dispute reported 06/30/2026 1223278738